Navigation Links
Pharmaceutical Pricing and Health Outcomes Top Trending News This Week from HealthEconomics.Com
Date:5/29/2013

Ponte Vedra Beach, FL (PRWEB) May 29, 2013

This week’s top news story on HealthEconomics.Com covered newly released survey results on Payer Strategies for Emerging Markets, conducted by Hanson Wade, based on interviews with Pharma/Biotech/Medical Device companies, Consulting companies, Academia, Regulators, and Providers. There was universal consensus among the respondents that, by 2018, more than one-third of pharmaceutical company revenues will come from emerging markets, including Brazil, Russia, Asia/Pac, Africa, among others. The greatest barrier to pharma growth in emerging markets was weak industry-payer partnerships (33% of respondents), followed by lack of out-of-pocket payer engagement (22%) and competition from generics (22%). Diabetes was thought to be the biggest potential therapeutic area, while Saudia Arabia followed by Nigeria were two countries of focus after BRIC TM (Brazil, Russia, India, China, Turkey, and Mexico) emerging markets. This story was sourced from Hanson Wade Limited.

The second most read story on HealthEconomics.Com was derived from an abstract by Dr. Gary Lyman, of Duke University and the Duke Cancer Institute in Durham, North Carolina, published in The Oncologist journal on May 22, 2013 discussing comparative effectiveness research (CER) in oncology. Oncology is a therapeutic area that is uniquely positioned to utilize CER to inform appropriate and optimal patient care, particularly among high-cost interventions. The author posits that the development and evaluation of genomic and other personalized medicine approaches poses significant challenges for CER in oncology. Lyman has written on this subject in other journals, including the Journal of Clinical Oncology.

Another popular news item on HealthEconomics.Com covered the latest addition to the HE-Artist series with a profile of Sean Sullivan, PhD, Professor and Associate Dean for Research at the University of Washington School of Pharmacy who is also a drummer and plays in a band of health economists called The Monte Carlos. Dr. Sullivan’s passion for drumming, coupled with his many contributions to the field of health economics and health policy, are featured in HE-Artists on HealthEconomics.Com.

About HealthEconomics.Com (http://www.healtheconomics.com):
A pioneer in the field, HealthEconomics.Com is the global authority in healthcare value and pharma market access. Each day, HealthEconomics.Com compiles the latest news, policy updates, resources, conferences, and jobs for BioPharma’s professionals involved in health economics, outcomes research, market access, and pricing. A trusted resource, HealthEconomics.Com’s comprehensive content is carefully selected by a discerning health economist editor, making it the most visited website for healthcare value and market access in the industry, with visitors encompassing all corners of the globe.

News Media interested in receiving the most current information on healthcare value and market access may obtain a free subscription to HealthEconomics.Com by visiting the site or by subscribing to the HealthEconomics.Com Newsletter.

Read the full story at http://www.prweb.com/releases/HealthEconomicsCom/TopNews/prweb10778875.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
2. MSU invention could help pharmaceutical industry save money
3. Nobel laureate to keynote international pharmaceutical conference at URI
4. 5 more pharmaceutical companies join NIH initiative to speed therapeutic discovery
5. Is it constitutional for states to regulate pharmaceutical gifts and meals to doctors?
6. Pharmica Consulting to Hold HIT Conference for the Pharmaceutical Industry
7. Scientists use sound waves to levitate liquids, improve pharmaceuticals
8. Medical care presents update on pharmaceutical health services research
9. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
10. Environmentally friendly chemistry important for manufacturing pharmaceuticals
11. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... September 22, 2017 , ... ... tick-borne diseases through research, education and awareness, today announced the appointment of Timothy ... and microbiologist, Dr. Sellati has more than 20 years of research experience with ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      ... things wrong, run afoul of The Quality System Regulation (§820.250), and Devicemakers find ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional ... http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and device marketing ... in compliance with FDA rules. , The FDA has issued two draft guidances ...
(Date:9/21/2017)... ... September 21, 2017 , ... Bill Howe Plumbing’s mission is to create ... back to the community. For over 37 years, they have operated with their mission ... plumbing in San Diego. They were chosen as the Best San Diego plumber ...
(Date:9/21/2017)... Southborough, Mass. (PRWEB) , ... September 21, 2017 , ... ... for children with autism, announced today the election of Yie-Hsin Hung to the Board ... Yie-Hsin Hung join our Board of Directors. Ms. Hung is an invaluable addition to ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... --  PDI , a leader in infection prevention products ... session focused on the role of chlorhexidine gluconate (CHG) ... 2017 Annual Scientific Meeting of the Association for Vascular ... Phoenix Convention Center in ... also feature PDI,s Prevantics® Device Swab as ...
(Date:9/5/2017)... , Sept. 5, 2017 Sapheneia and ... DoseCheck solution. Scannerside DoseCheck is a third-party Vendor neutral ... CT scanners and allows compliance with current MITA standards. ... proprietary XR 29 DoseCheck solution is specifically designed to ... alerts of potential radiation doses over a predefined threshold. ...
(Date:9/5/2017)... , Sept. 5, 2017  Just 18 months after ... is pleased to announce the appointment of three new ... Wynne , Dominic Jones-Phillips and James ... Tammy Wynne ... of market access writers. She has over ten years, ...
Breaking Medicine Technology: